
News: U.S. and World News Headlines : NPR
2 days ago · NPR news, audio, and podcasts. Coverage of breaking stories, national and world news, politics, business, science, technology, and extended coverage of major national and world events.
The anatomy of an NPR headline : NPR Public Editor : NPR
Apr 17, 2025 · The goal of a good headline is multipronged, according to Thomas Evans, managing editor, editorial review, who joined NPR last fall to lead the creation of what's called the "Backstop."
Latin superstar Bad Bunny will headline the 2026 Super Bowl ... - NPR
Sep 29, 2025 · Puerto Rican rapper and singer Bad Bunny will headline next year's Super Bowl halftime show.
How to write great headlines that keep readers engaged
Oct 25, 2015 · So when you're writing your headline, make sure people can easily understand it. Keep it simple — avoid names and acronyms that aren't universally recognized.
Politics : NPR
2 days ago · NPR's expanded coverage of U.S. and world politics, the latest news from Congress and the White House and elections.
Kendrick Lamar will headline next year's Super Bowl halftime show - NPR
Sep 8, 2024 · Kendrick Lamar will headline next year's Super Bowl halftime show September 8, 20242:43 PM ET Emma Bowman
NPR - Breaking News, Analysis, Music, Arts & Podcasts
Top stories in the U.S. and world news, politics, health, science, business, music, arts and culture. Nonprofit journalism with a mission. This is NPR.
New York City’s 1975 debt crisis and how the city almost went ... - NPR
Oct 15, 2025 · But President Gerald Ford was adamantly opposed to bailing out NYC, prompting the famous New York Daily News headline — "Ford to City: Drop Dead."
2024 Election: Trump wins 2nd term as president | NPR
“America elects Donald Trump president, spelling change for [South Africa] and the world,” one headline on popular South African media website News24 read.
Trump aims to lower drug prices with new executive order : Shots ...
May 12, 2025 · President Trump wants to lower drug prices in the U.S. by tying them to the prices paid in other developed countries. The pharmaceutical industry has long opposed the approach.